Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.276
+0.003 (0.99%)
At close: Nov 20, 2024, 4:00 PM
0.301
+0.025 (9.22%)
After-hours: Nov 20, 2024, 6:40 PM EST
Vincerx Pharma Employees
Vincerx Pharma had 42 employees as of December 31, 2023. The number of employees increased by 1 or 2.44% compared to the previous year.
Employees
42
Change (1Y)
1
Growth (1Y)
2.44%
Revenue / Employee
n/a
Profits / Employee
-$643,571
Market Cap
9.25M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42 | 1 | 2.44% |
Dec 31, 2022 | 41 | -15 | -26.79% |
Dec 31, 2021 | 56 | 28 | 100.00% |
Dec 31, 2020 | 28 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Evogene | 142 |
RedHill Biopharma | 53 |
Jaguar Health | 49 |
Vaccinex | 40 |
FOXO Technologies | 29 |
Soligenix | 15 |
COSCIENS Biopharma | 12 |
SeaStar Medical Holding | 12 |
VINC News
- 6 weeks ago - Penny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer Candidates - Benzinga
- 6 weeks ago - Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates - GlobeNewsWire
- 3 months ago - Vincerx Pharma Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - GlobeNewsWire
- 7 months ago - Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - GlobeNewsWire
- 8 months ago - Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewsWire
- 8 months ago - Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update - GlobeNewsWire